RT Book, Section
A1 Xiang, David
A1 Shah, Harsh
SR Print(0)
ID 1188169504
T1 Relatlimab and nivolumab provide greater survival benefit for advanced melanoma
T2 2 Minute Medicine
YR 2015
FD 2015
PB McGraw Hill
PP New York, NY
SN 
LK accessmedicina.mhmedical.com/updatesContent.aspx?gbosid=579756
RD 2023/12/05
AB